[
    [
        {
            "time": "",
            "orginal_text": "复星医药：第七届董事会第七十一次会议(临时会议)决议公告",
            "features": {
                "keywords": [
                    "复星医药",
                    "董事会",
                    "决议公告"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "复星医药：第七届董事会第七十一次会议(临时会议)决议公告",
            "scores": {
                "News_content": "复星医药：第七届董事会第七十一次会议(临时会议)决议公告",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 4,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "公告精选：高升控股遭立案调查 思特奇股东拟减持不超20.43%股份 减持股份",
            "features": {
                "keywords": [
                    "高升控股",
                    "立案调查",
                    "思特奇",
                    "减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "公告精选：高升控股遭立案调查 思特奇股东拟减持不超20.43%股份 减持股份",
            "scores": {
                "News_content": "公告精选：高升控股遭立案调查 思特奇股东拟减持不超20.43%股份 减持股份",
                "Correlation": 3,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "复宏汉霖撤回新三板挂牌申请 拟赴港上市",
            "features": {
                "keywords": [
                    "复宏汉霖",
                    "新三板",
                    "撤回",
                    "赴港上市"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复宏汉霖撤回新三板挂牌申请 拟赴港上市",
            "scores": {
                "News_content": "复宏汉霖撤回新三板挂牌申请 拟赴港上市",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "撤回新三板挂牌申请 复星医药控股子公司复宏汉霖拟赴港上市",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "新三板",
                    "撤回",
                    "赴港上市"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "撤回新三板挂牌申请 复星医药控股子公司复宏汉霖拟赴港上市",
            "scores": {
                "News_content": "撤回新三板挂牌申请 复星医药控股子公司复宏汉霖拟赴港上市",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "布局智能手机超声成像仪 复星医药斥资1.06亿美元投资BNI",
            "features": {
                "keywords": [
                    "复星医药",
                    "智能手机",
                    "超声成像仪",
                    "投资",
                    "BNI"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "布局智能手机超声成像仪 复星医药斥资1.06亿美元投资BNI",
            "scores": {
                "News_content": "布局智能手机超声成像仪 复星医药斥资1.06亿美元投资BNI",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "[公告摘要]复星医药(02196.HK)：复宏汉霖撤回新三板上市申请并拟于港交所主板上市",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "新三板",
                    "撤回",
                    "港交所",
                    "主板上市"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[公告摘要]复星医药(02196.HK)：复宏汉霖撤回新三板上市申请并拟于港交所主板上市",
            "scores": {
                "News_content": "[公告摘要]复星医药(02196.HK)：复宏汉霖撤回新三板上市申请并拟于港交所主板上市",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "复星医药1.06亿美元投资BNI 布局智能手机超声成像仪",
            "features": {
                "keywords": [
                    "复星医药",
                    "投资",
                    "BNI",
                    "智能手机",
                    "超声成像仪"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药1.06亿美元投资BNI 布局智能手机超声成像仪",
            "scores": {
                "News_content": "复星医药1.06亿美元投资BNI 布局智能手机超声成像仪",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "复星医药：复宏汉霖撤回新三板上市申请 拟赴港上市 IPO融资异常",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "新三板",
                    "撤回",
                    "赴港上市",
                    "IPO",
                    "融资异常"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "复星医药：复宏汉霖撤回新三板上市申请 拟赴港上市 IPO融资异常",
            "scores": {
                "News_content": "复星医药：复宏汉霖撤回新三板上市申请 拟赴港上市 IPO融资异常",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "股市快讯：午后生物制品走强 华兰生物涨逾7%",
            "features": {
                "keywords": [
                    "生物制品",
                    "华兰生物",
                    "涨逾7%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "股市快讯：午后生物制品走强 华兰生物涨逾7%",
            "scores": {
                "News_content": "股市快讯：午后生物制品走强 华兰生物涨逾7%",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药股集体大涨 机构揭秘打好四季度“反击战”的三条思路",
            "features": {
                "keywords": [
                    "医药股",
                    "大涨",
                    "四季度",
                    "反击战"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药股集体大涨 机构揭秘打好四季度“反击战”的三条思路",
            "scores": {
                "News_content": "医药股集体大涨 机构揭秘打好四季度“反击战”的三条思路",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "97个药品通过一致性评价 可能将放弃GPO？",
            "features": {
                "keywords": [
                    "药品",
                    "一致性评价",
                    "GPO"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "97个药品通过一致性评价 可能将放弃GPO？",
            "scores": {
                "News_content": "97个药品通过一致性评价 可能将放弃GPO？",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "北上资金成交额剧增 继续加仓白酒龙头",
            "features": {
                "keywords": [
                    "北上资金",
                    "成交额剧增",
                    "白酒龙头"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "北上资金成交额剧增 继续加仓白酒龙头",
            "scores": {
                "News_content": "北上资金成交额剧增 继续加仓白酒龙头",
                "Correlation": 2,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]